PRKG1 and neoplasm: The elevation of intracellular cGMP levels by cGMP PDE inhibitors can activate cGMP-dependent protein kinases (PKG), although the downstream pathways responsible for suppressing proliferation and inducing apoptosis of tumor cells are not well understood.